Slow, Steady Tx Release

San Diego - The most current data from an open label trial show that hydroquinone 4 percent with retinol is an effective and safe option to treat melasma and post-inflammatory hyperpigmentation, according to Pearl Grimes, M.D., the study's principal investigator.

Related Videos
Experts discuss plaque psoriasis.
Experts discuss treating plaque psoriasis.
Related Content

How to Educate Patients on Sun Protection

May 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis

May 26th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

The Mainstream Patient: May 26

May 26th 2023

How to Educate Patients on Sun Protection

May 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis

May 26th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

The Mainstream Patient: May 26

May 26th 2023

How to Educate Patients on Sun Protection

May 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis

May 26th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

The Mainstream Patient: May 26

May 26th 2023
© 2023 MJH Life Sciences

All rights reserved.